3,3'-Diethyloxacarbocyanine iodide
3,3'-Diethyloxacarbocyanine iodide structure
|
Common Name | 3,3'-Diethyloxacarbocyanine iodide | ||
|---|---|---|---|---|
| CAS Number | 905-96-4 | Molecular Weight | 460.31 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H21IN2O2 | Melting Point | 278ºC (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of 3,3'-Diethyloxacarbocyanine iodide3,3'-Diethyloxacarbocyanine iodide is a microviscosity probe for micelles and microemulsions[1]. |
| Name | C3-oxacyanine |
|---|---|
| Synonym | More Synonyms |
| Description | 3,3'-Diethyloxacarbocyanine iodide is a microviscosity probe for micelles and microemulsions[1]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 278ºC (dec.)(lit.) |
|---|---|
| Molecular Formula | C21H21IN2O2 |
| Molecular Weight | 460.31 |
| Exact Mass | 460.06500 |
| PSA | 35.09000 |
| LogP | 1.08680 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
|
~%
3,3'-Diethyloxa... CAS#:905-96-4 |
| Literature: Journal of the Chemical Society, , p. 2801 Journal of the Chemical Society, , p. 1478 |
|
~%
3,3'-Diethyloxa... CAS#:905-96-4 |
| Literature: Kagaku Kenkyusho Hokoku, , vol. 30, p. 39,40 Chem.Abstr., , p. 93 |
|
~%
3,3'-Diethyloxa... CAS#:905-96-4 |
| Literature: Collection of Czechoslovak Chemical Communications, , vol. 37, p. 2273 - 2281 |
|
~%
3,3'-Diethyloxa... CAS#:905-96-4 |
| Literature: US2537880 , ; |
|
TLR signaling modulates side effects of anticancer therapy in the small intestine.
J. Immunol. 194(4) , 1983-95, (2015) Intestinal mucositis represents the most common complication of intensive chemotherapy, which has a severe adverse impact on quality of life of cancer patients. However, the precise pathophysiology re... |
|
|
Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
Sci. Rep. 5 , 16887, (2015) Mutant huntingtin (mHtt) aggregation in the nucleus is the most readily apparent phenotype and cause of neuronal death in Huntington's disease (HD). Inhibiting mHtt aggregation reduces cell death in t... |
|
|
Structure-activity relationship of cyanine tau aggregation inhibitors.
J. Med. Chem. 52 , 3539-47, (2009) A structure-activity relationship for symmetrical cyanine inhibitors of human tau aggregation was elaborated using a filter trap assay. Antagonist activity depended on cyanine heterocycle, polymethine... |
| G 1745 |
| MFCD00011952 |
| DOC Iodide |
| (2Z)-3-ethyl-2-[(E)-3-(3-ethyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]-1,3-benzoxazole,iodide |
| 3,3'-dietyl oxacarbocyanine iodide |
| EINECS 212-996-6 |